Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (124)

« Back to Publications

TF4-mediated stress response as a therapeutic vulnerability in chordoma.

Cottone L. et al, (2025), Mol Oncol

DNA demethylation-mediated downregulation of MNX1 in acute myeloid leukemia.

Kelekçi S. et al, (2025), Leukemia, 39, 2270 - 2274

Epigenetic drug screening identifies enzyme inhibitors A-196 and TMP-269 as novel regulators of sprouting angiogenesis.

Beter M. et al, (2025), Sci Rep, 15

TF4-Mediated Metabolic Stress Response as a Therapeutic Vulnerability in Chordoma

Cottone L. et al, (2025)

The pRb/RBL2-E2F1/4-GCN5 axis regulates cancer stem cell formation and G0 phase entry/exit by paracrine mechanisms.

Chang C-H. et al, (2024), Nat Commun, 15

BRD9-SMAD2/3 Orchestrates Stemness and Tumorigenesis in Pancreatic Ductal Adenocarcinoma.

Feng Y. et al, (2024), Gastroenterology, 166, 139 - 154

Structural and non-coding variants increase the diagnostic yield of clinical whole genome sequencing for rare diseases.

Pagnamenta AT. et al, (2023), Genome Med, 15

HSD3B1 is an oxysterol 3β-hydroxysteroid dehydrogenase in human placenta.

Dickson A. et al, (2023), Open Biol, 13

Discovery of a Potent and Selective Naphthyridine-Based Chemical Probe for Casein Kinase 2.

Davis-Gilbert ZW. et al, (2023), ACS Med Chem Lett, 14, 432 - 441

BRD9-SMAD2/3 orchestrates stemness and tumorigenesis in pancreatic ductal adenocarcinoma.

Feng Y. et al, (2023), bioRxiv

Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma.

Kurata K. et al, (2023), Blood Cancer J, 13

Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma.

Kurata K. et al, (2023), Blood Cancer J, 13

BRD9-containing non-canonical BAF complex maintains somatic cell transcriptome and acts as a barrier to human reprogramming.

Sevinç K. et al, (2022), Stem Cell Reports, 17, 2629 - 2642

HSD3B1 is an Oxysterol 3β-Hydroxysteroid Dehydrogenase in Human Placenta

Dickson A. et al, (2022)

Bisphosphonates: The role of chemistry in understanding their biological actions and structure-activity relationships, and new directions for their therapeutic use.

Ebetino FH. et al, (2022), Bone, 156

Load More

1
2
3
4
5
6
7
...
»